These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31554206)

  • 1. Toll-Like Receptors-2 and -4 in Graves' Disease-Key Players or Bystanders?
    Polak A; Grywalska E; Klatka J; Roliński J; Matyjaszek-Matuszek B; Klatka M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
    Bossowski A; Urban M; Stasiak-Barmuta A
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
    Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
    Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells.
    Han H; Fu X; Huang J; Zhang X; Yu J
    J Toxicol Sci; 2020; 45(11):701-711. PubMed ID: 33132244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic profiling in CD4+ and CD8+ T cells from Graves' disease patients reveals changes in genes associated with T cell receptor signaling.
    Limbach M; Saare M; Tserel L; Kisand K; Eglit T; Sauer S; Axelsson T; Syvänen AC; Metspalu A; Milani L; Peterson P
    J Autoimmun; 2016 Feb; 67():46-56. PubMed ID: 26459776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer.
    Diakowska D; Nienartowicz M; Grabowski K; Rosińczuk J; Krzystek-Korpacka M
    Adv Clin Exp Med; 2019 Apr; 28(4):515-522. PubMed ID: 29968427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors.
    Douglas RS; Brix TH; Hwang CJ; Hegedüs L; Smith TJ
    J Clin Endocrinol Metab; 2009 May; 94(5):1797-802. PubMed ID: 19240157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
    Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
    Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.
    Zhao J; Lin B; Deng H; Zhi X; Li Y; Liu Y; Bible PW; Li Q; Xu B; Wei L; Yang H; Huang D
    Curr Mol Med; 2018; 18(2):83-90. PubMed ID: 29974826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases.
    Inoue N; Katsumata Y; Watanabe M; Ishido N; Manabe Y; Watanabe A; Masutani R; Hidaka Y; Iwatani Y
    Autoimmunity; 2017 May; 50(3):182-191. PubMed ID: 28013570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High expression of ICOS on CD4
    Chen X; Wang F; Cong X; Shen Q; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1102-1108. PubMed ID: 33325362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequencies of PD-1- positive T CD3+CD4+, T CD3+CD8+ and B CD19+ lymphocytes in female patients with Graves' disease and healthy controls- preliminary study.
    Pyzik A; Grywalska E; Matyjaszek-Matuszek B; Smoleń A; Pyzik D; Roliński J
    Mol Cell Endocrinol; 2017 Jun; 448():28-33. PubMed ID: 28284988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between OX40/4-1 BB (CD134/CD137) costimulatory molecules expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease].
    Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):133-40. PubMed ID: 16232366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patency of Litomosoides sigmodontis infection depends on Toll-like receptor 4 whereas Toll-like receptor 2 signalling influences filarial-specific CD4(+) T-cell responses.
    Rodrigo MB; Schulz S; Krupp V; Ritter M; Wiszniewsky K; Arndts K; Tamadaho RS; Endl E; Hoerauf A; Layland LE
    Immunology; 2016 Apr; 147(4):429-42. PubMed ID: 26714796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different interleukin-17-secreting Toll-like receptor
    Ferreira TB; Hygino J; Wing AC; Kasahara TM; Sacramento PM; Camargo S; Rueda F; Alves-Leon SV; Alvarenga R; Vasconcelos CC; Agrawal A; Gupta S; Bento CAM
    Immunology; 2018 Jun; 154(2):239-252. PubMed ID: 29168181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy.
    Pawlowski P; Mysliwiec J; Stasiak-Barmuta A; Bakunowicz-Lazarczyk A; Gorska M
    Folia Histochem Cytobiol; 2009; 47(1):29-33. PubMed ID: 19419934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pattern of peripheral lymphocyte subsets in Graves' disease with persistency of anti-TSHR autoantibodies.
    Teniente-Serra A; Soldevila B; Quirant-Sánchez B; Fernández MA; Ester Condins A; Puig-Domingo M; Pujol-Borrell R; Martínez-Cáceres EM
    Autoimmunity; 2019; 52(5-6):220-227. PubMed ID: 31366254
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.